A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Cancer Lung Cancer Non-Small Cell Lung Cancer (NSCLC)
For the latest version of this information please go to www.forpatients.roche.com